SCHEDULE 13G/A
Statement of Beneficial Ownership
IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0000950170-25-021219
Stakes reported in this filing
| Reporting person | Shares | Of the class |
|---|---|---|
| Perceptive Advisors LLC | 22,112,266 | 7.3% |
| Joseph Edelman | 22,112,266 | 7.3% |
| Perceptive Life Sciences Master Fund, Ltd. | 22,112,266 | 7.3% |
Members of a group can each report the same shares, so these rows overlap and don't add up.
Stake history · largest stake in each 13D and 13G
- 2026-11-10 SCHEDULE 13G · STATE STREET CORPORATION 4.8%
- 2026-08-07 SCHEDULE 13G · STATE STREET CORPORATION 5.5%
- 2026-07-28 SCHEDULE 13G/A · BlackRock, Inc. 7.5%
- 2026-05-12 SCHEDULE 13G · STATE STREET CORPORATION 4.2%
- 2026-03-27 SCHEDULE 13G/A · The Vanguard Group 0%
- 2026-02-09 SCHEDULE 13G · STATE STREET CORPORATION 5.1%
- 2025-07-29 SCHEDULE 13G/A · The Vanguard Group 7.50%
- 2025-07-17 SCHEDULE 13G/A · BlackRock, Inc. 6.4%
- 2025-05-15 SCHEDULE 13G/A · Perceptive Advisors LLC 3.8%
- 2025-02-14 SCHEDULE 13G/A · Perceptive Advisors LLC 7.3%
- 2024-11-14 SC 13G/A · Perceptive Advisors LLC 8.8%
- 2024-03-01 SC 13G · Perceptive Advisors LLC 6.9%
- 2023-10-27 SC 13D/A · Quogue Capital LLC 15.84%
- 2021-02-12 SC 13G/A · Avoro Capital Advisors LLC 5.1%
Loading xslSCHEDULE_13G_X01/primary_doc.xml…